Although GLP-1 medications are among the top medications in terms of total expense in the pharmacy benefits, the benefits of GLP-1 have been unveilling
(August 2021)
Factors that may disrupt healthy estrogen detoxification include alcohol, insulin resistance, obesity, oral contraceptives, and HRT
Burkets Oral Medicine
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
Some people feel very little at this stage, which is normal